# Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

> **NCT00315523** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 403 (—)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** Levocetirizine

## Key facts

- **NCT ID:** NCT00315523
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 403 (—)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315523, "Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00315523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*